Clinical Trial Update: Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of allogeneic mesenchymal stem cell infusion therapy for endothelial dysfunction in diabetic patients with symptomatic ischemic heart…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Ischemic Heart Disease

Drugs mentioned

• Allogeneic mesenchymal stem cell infusion therapy (ACESO-IHD) (mesenchymal stem cell infusion therapy)

Snippet

Sponsor: Joshua M Hare | Conditions: Diabetes Mellitus, Ischemic Heart Disease | Phase 1, Phase 2 | Status: COMPLETED